ABL1 and cancer: Bcr-Abl-dependent mechanisms primarily result from the acquisition of point mutations in the BCR:ABL gene, although other rarer mechanisms occur, such as BCR:ABL gene amplification and hyperexpression, or mutations in other cancer-related genes [5,7].